2020
DOI: 10.2147/ppa.s266697
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Oral Bisphosphonate Compliance Focusing on Switching of Prescription Pattern

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 39 publications
0
3
0
Order By: Relevance
“…[3,4] Given the chronic nature and prolonged treatment required for this disease, https://doi.org/10.11005/jbm.2024.31.1.63 drug compliance is essential for successful treatment. [5] However, adherence to osteoporosis medications is known to be suboptimal, varying from 34% to 75% in the first year of treatment [6,7] and persistence levels at 1 year were reported to be between 18% and 75%. [8] This suboptimal adherence and persistence not only lead to increased fracture rate but also result in worse health outcomes.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[3,4] Given the chronic nature and prolonged treatment required for this disease, https://doi.org/10.11005/jbm.2024.31.1.63 drug compliance is essential for successful treatment. [5] However, adherence to osteoporosis medications is known to be suboptimal, varying from 34% to 75% in the first year of treatment [6,7] and persistence levels at 1 year were reported to be between 18% and 75%. [8] This suboptimal adherence and persistence not only lead to increased fracture rate but also result in worse health outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…[9,10] Therefore, research aimed at improving compliance must be prioritized. [5] Various factors including dosing requirements, medical insurance impediments, medication, costs, side-effects of medications, and patient-physician rapport are mentioned, [11,12] but their effect on compliance is not fully understood. Recently, patient perception has been found to predict adherence to medication in a variety of chronic conditions [13] including osteoporosis.…”
Section: Introductionmentioning
confidence: 99%
“…It was reported one-year compliance was lower than 25% in all osteoporosis therapies, leaving patients with higher risk for fractures and public health costs. [7] Among the antiresorptive osteoporosis drugs, there are numerus studies on compliance of BP, [8][9][10][11][12][13][14] whereas, there are relatively few studies on compliance of SERM. [3,15,16] The primary objective of this study was (1) to evaluate the compliance to SERM medication in postmenopausal women with osteoporosis; and (2) to determine the risk of osteoporotic fractures according to the compliance or other patient characteristics, using the Korean National Health Insurance (KNHI) claims database.…”
Section: Introductionmentioning
confidence: 99%